2611 - 2620 of 6082 Results
Title
Year
- Gait analysis may distinguish progressive supranuclear palsy and Parkinson disease since the earliest stages2021OPENTitle: Gait analysis may distinguish progressive supranuclear palsy and Parkinson disease since the earliest stagesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-88877-2Best OA location URL: https://www.nature.com/articles/s41598-021-88877-2.pdfCitation Count: 24
- An Open‐Label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel in Cervical Dystonia2021OPENTitle: An Open‐Label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel in Cervical DystoniaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 5Start Page: 743End Page: 749Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13229Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13229Citation Count: 8
-
OPENTitle: Cell-Type Specific Changes in DNA Methylation of SNCA Intron 1 in Synucleinopathy BrainsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.652226Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.652226/pdfCitation Count: 14
- Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS Study2021OPENTitle: Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1853End Page: 1862Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28596Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28596Citation Count: 34
- Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients2021OPENTitle: Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 25End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.012Best OA location URL: http://www.prd-journal.com/article/S1353802021001450/pdfCitation Count: 19
- Integrating protein networks and machine learning for disease stratification in the Hereditary Spastic Paraplegias2021OPENTitle: Integrating protein networks and machine learning for disease stratification in the Hereditary Spastic ParaplegiasJournal Name: iSciencePublisher: Elsevier BVVol: 24Issue #: 5Start Page: 102484End Page: 102484Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.isci.2021.102484Best OA location URL: http://www.cell.com/article/S2589004221004521/pdfCitation Count: 9
- Measuring Patient Preferences at the FDA Center for Devices and Radiological Health: Reflections and Projections2021OPENTitle: Measuring Patient Preferences at the FDA Center for Devices and Radiological Health: Reflections and ProjectionsJournal Name: Value in HealthPublisher: Elsevier BVVol: 24Issue #: 7Start Page: 1024End Page: 1029Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.jval.2021.01.009Best OA location URL: http://www.valueinhealthjournal.com/article/S109830152100139X/pdfCitation Count: 3
- The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics2021OPENTitle: The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemicsJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 21Issue #: 6Start Page: 615End Page: 623Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/14737175.2021.1923480Best OA location URL: https://doi.org/10.1080/14737175.2021.1923480Citation Count: 16
- Glucocerebrosidase Activity is Reduced in Cryopreserved Parkinson’s Disease Patient Monocytes and Inversely Correlates with Motor Severity2021OPENTitle: Glucocerebrosidase Activity is Reduced in Cryopreserved Parkinson’s Disease Patient Monocytes and Inversely Correlates with Motor SeverityJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1157End Page: 1165Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202508Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202508?id=journal-of-parkinsons-disease%2Fjpd202508Citation Count: 17
- Memory enhancement by multidomain group cognitive training in patients with Parkinson’s disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial2021OPENTitle: Memory enhancement by multidomain group cognitive training in patients with Parkinson’s disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trialJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 12Start Page: 4655End Page: 4666Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10568-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10568-9.pdfCitation Count: 17